Pink Sheet: “Lung Cancer ‘Master Protocol’ Eyed As Paradigm-Changing Approach to Drug Development” November 18, 2013 Share
Boston Globe: “Foundation Medicine is part of an effort to advance new clinical trial design in lung cancer” November 7, 2013 Share
Wall Street Journal: “Foundation Medicine Partners with Broad-based Coalition to Advance Revolutionary New Clinical Trial Design in Lung Cancer” (Press Release) November 7, 2013 Share
The ASCO Post: “’Master Protocol’ Could Revolutionize Trials in Lung Cancer, Eventually Other Cancers” November 1, 2013 Share
RPM Report: “Landmark Trial for Personalized Medicine Coming Soon: NGS Approval May Be One Offshoot of Lung Cancer ‘Master Protocol’” April 18, 2013 Share
